癌症中的EIF4家族和圆形RNA之间的分子相互作用:机制和治疗方法
Jia Song1, Yuexin Ge1, Mingyan Dong1
1Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, PR China; Liaoning Key Laboratory of Molecular Targeted Anti-tumor Drug Development and Evaluation, China Medical University, Shenyang, 110122, PR China.
European journal of pharmacology
|June 27, 2023
概括
欧核细胞转化启动因子4 (EIF4) 家族影响癌症的发展. 循环RNAs (circRNAs) 与EIF4s相互作用,为癌症治疗提供潜在的治疗点.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 细胞转化启动因子4 (EIF4) 家族对于mRNA招募到核糖体至关重要,在细胞转化中发挥关键作用.
- EIF4家族成员的失调与癌症的发病和进展有关.
- 循环RNAs (circRNAs) 正在成为癌症中的重要分子,具有作为诊断生物标志物和治疗点的潜力.
研究的目的:
- 审查EIF4家族在癌症中的作用.
- 探索circRNAs和EIF4s之间的复杂相互作用.
- 讨论针对EIF4s的基于circRNA的治疗方法在癌症研究中的潜力.
主要方法:
- 对癌症中EIF4家族的新兴研究的文献综述.
- 对调控circRNA-EIF4相互作用的分子通路的分析.
- 评估针对EIF4s的基于circRNA的治疗策略.
主要成果:
- 在各种癌症中,EIF4家族成员显著失调.
- EIF4s影响circRNA生物发生,运输和功能.
- 循环RNA可以通过特定的分子机制调节EIF4的表达.
结论:
- circRNAs和EIF4s之间的复杂关系为癌症诊断和治疗提供了新的途径.
- 用基于circRNA的疗法准EIF4s对临床癌症研究具有前景.
- 为了开发有效的癌症疗法,需要对circRNA-EIF4相互作用进行进一步的研究.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
siRNA - Small Interfering RNAs
16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


